Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
26.9M
-
Shares change
-
+3.86M
-
Total reported value, excl. options
-
$317M
-
Value change
-
+$45.6M
-
Number of buys
-
33
-
Number of sells
-
-24
-
Price
-
$11.78
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q1 2021
76 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.9M shares
of 54M outstanding shares and own 49.8% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5.96M shares), RTW INVESTMENTS, LP (3.21M shares), FMR LLC (2.42M shares), TRV GP IV, LLC (2.34M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.53M shares), Casdin Capital, LLC (1.24M shares), BlackRock Inc. (1.13M shares), COWEN AND COMPANY, LLC (882K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (876K shares), and VANGUARD GROUP INC (843K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.